In the current study which did not undergo peer review the researchers assessed the likelihood of a dementia diagnosis within 5 years of starting a GLP-1 receptor agonist or another diabetes medication using a cohort of 549,822 patients aged 60 years or older with type 2 diabetes
If youre serious about your routine, this is where quality truly separates the gimmicks from the good stuff
Untreated chronic obesity can progress into diabetes, heart disease, sleep apnea, kidney disease, disability and other expensive conditions
More research is needed, including more research about newer GLP-1s, such as Ozempic
The remaining four letters cite 21 CFR 1271.3(f)(1), the requirement for minimal manipulation of HCTPs, and warn companies with products that have been processed to the point where the original characteristics have been altered